Federal award
CMC PHARMACEUTICALS, INC.
W911SR22C0047
ContractSBIR/STTR SR2
Obligated and Ceiling
- Obligated (net)
- $1,099,975.08
- Ceiling (potential value, not spending)
- $1,099,975.08
- Current value
- $1,099,975.08
- Gross positive obligations
- $1,099,975.08
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- CMC PHARMACEUTICALS, INC. · R9AVS7XL2YB4
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- CMC PHARMACEUTICALS, INC. · R9AVS7XL2YB4
- Awarding agency
- Department of War · sub-agency 2100 · office W911SR
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AC12 · NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH
- Industry (NAICS)
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- PIID
- W911SR22C0047
- Award type code
- D
- Actions
- 2 · Sep 22, 2022 to Oct 19, 2023
- Why it is listed
- gross positive obligations of $100k or more (contracts); SBIR/STTR award
Action History2
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Oct 19, 2023 | FY2024 | P00001 | G | $225,350.28 | — |
| Sep 22, 2022 | FY2022 | 0 | — | $874,624.80 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.